OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?
Kamila Sabino Batista, Juliana Gondim de Albuquerque, Maria Helena Araújo de Vasconcelos, et al.
Nutrition Research Reviews (2021) Vol. 36, Iss. 2, pp. 181-198
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Synthesis and Functions of Resistant Starch
Zhanggui Wang, Shu‐Li Wang, Qinhong Xu, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 5, pp. 1131-1144
Open Access | Times Cited: 41

Role of Probiotics in the Management of COVID-19: A Computational Perspective
Quang Vo Nguyen, Li Chuin Chong, Yan-Yan Hor, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 274-274
Open Access | Times Cited: 50

Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases
Xinquan Li, Qiang Wang, Xiafen Hu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 37

Pathophysiology of acute lung injury in patients with acute brain injury: the triple-hit hypothesis
Mairi Ziaka, Aristomenis K. Exadaktylos
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 6

The antiviral effects and underlying mechanisms of probiotics on viral infections
Nahid Javanshir, Valimohammad Ebrahimi, Zakieh Mazhari, et al.
Microbial Pathogenesis (2025), pp. 107377-107377
Closed Access

Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 34

Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications
Maha Fahad Alenazy, Haya I. Aljohar, Ashwag R. Alruwaili, et al.
Metabolites (2022) Vol. 12, Iss. 10, pp. 912-912
Open Access | Times Cited: 27

Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support
Marta Giovanetti, Gianfranco Pannella, Annamaria Altomare, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 370-370
Open Access | Times Cited: 4

Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial
Mohammad Reza Aghasadeghi, Mohammad Ali Zaheri Birgani, Saeedreza Jamalimoghadamsiyahkali, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

The central role of the gut in intensive care
Alberto Corriero, Raffaella Maria Gadaleta, Filomena Puntillo, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 25

Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis
Lei Xu, Chung S. Yang, Yanan Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22

Unravelling the gut-lung axis: insights into microbiome interactions and Traditional Indian Medicine's perspective on optimal health
Swati Haldar, Snehal Jadhav, Vandana Gulati, et al.
FEMS Microbiology Ecology (2023) Vol. 99, Iss. 10
Open Access | Times Cited: 13

Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions
Yong Qiu, Chunheng Mo, Lu Chen, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 4

Applications of Probiotic-Based Multi-Components to Human, Animal and Ecosystem Health: Concepts, Methodologies, and Action Mechanisms
Sonagnon Kouhoundé, Kifouli Adéoti, Majid Mounir, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1700-1700
Open Access | Times Cited: 16

Non-dairy prebiotics: Conceptual relevance with nutrigenomics and mechanistic understanding of the effects on human health
Rajni Devi, Eshita Sharma, Richa Thakur, et al.
Food Research International (2023) Vol. 170, pp. 112980-112980
Closed Access | Times Cited: 9

Evaluation of the effect of kefir supplementation on inflammatory markers and clinical and hematological indices in COVID-19 patients; a randomized double-blined clinical trial
Ramin Gooruee, Naseh Pahlavani, Vahid Hadi, et al.
Advances in Integrative Medicine (2023) Vol. 11, Iss. 1, pp. 10-16
Closed Access | Times Cited: 6

Microbiome modulators in the treatment of infectious diseases: insights from clinical trials
Shidong Wang, Congying Wang, Ling Shen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Disruption of the lung-gut-brain axis is responsible for cortex damage induced by pulmonary exposure to zinc oxide nanoparticles
Lingbing Zhang, Yandan Zhang, Xuejun Jiang, et al.
Toxicology (2022) Vol. 485, pp. 153390-153390
Closed Access | Times Cited: 8

Effect of Kefir Produced from Cow Milk on Clinical Outcomes and Immune Response of Patients with COVID-19: A Randomized Clinical Trial
Ramin Gooruee, Naseh Pahlavani, Vahid Hadi, et al.
Annals of Military and Health Sciences Research (2023) Vol. 20, Iss. 4
Open Access | Times Cited: 2

Prebiotics and Probiotics Food
P. Sankarganesh, Samuel Ayofemi Olalekan Adeyeye, Ashok Kumar Chakka, et al.
(2024), pp. 551-583
Closed Access

Emerging therapeutics in the treatment of chronic respiratory disorders
Dhruv Gupta, Rahul Dinkar Shingte, Divya Suares
Elsevier eBooks (2024), pp. 51-97
Closed Access

Human Microbiome, Virome, and Microbial Therapies Against COVID-19
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 423-455
Closed Access

Page 1 - Next Page

Scroll to top